Finished Dosage Forms (Drug Products)

Head office: Rijswijk, the Netherlands

 

Our Drug Products Business Unit is a global unit and responsible for our B2B generic finished dosage forms.

 

What sets Centrient Pharmaceuticals apart is our full backward integration and control of our supply chain. We have the advantage of using our own high quality APIs (PureActives®), in our beta-lactam and statin products, which deliver unique quality and performance in the finished dosage formulation.

 

On the basis of our unique APIs, we offer our marketing partners a one-stop-shop solution for worry-free generic finished dosage forms. Based on our vertically integrated production capabilities and paired with our extensive regulatory know-how, doing business with Centrient Pharmaceuticals enables you to focus on what truly counts: your business and your customers.

 

Contact:

Centrient Pharmaceuticals

Business Unit Drug Products

P.O. Box 425

2600 AK Delft

The Netherlands

 

E-mail: licensing@centrient.com

Copyright © 2018 Centrient Pharmaceuticals

Join the conversation

Follow us on Facebook Follow us on Twitter Follow us on LinkedIn
Follow us on Facebook Follow us on Twitter Follow us on LinkedIn